IRADIMED Balance Sheet Health
Financial Health criteria checks 6/6
IRADIMED has a total shareholder equity of $71.4M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $92.2M and $20.7M respectively. IRADIMED's EBIT is $20.0M making its interest coverage ratio -10.7. It has cash and short-term investments of $49.8M.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | -10.7x |
Cash | US$49.76m |
Equity | US$71.42m |
Total liabilities | US$20.74m |
Total assets | US$92.16m |
Recent financial health updates
No updates
Recent updates
If EPS Growth Is Important To You, IRadimed (NASDAQ:IRMD) Presents An Opportunity
Feb 23Getting In Cheap On IRadimed Corporation (NASDAQ:IRMD) Is Unlikely
Feb 07Should You Investigate IRadimed Corporation (NASDAQ:IRMD) At US$45.06?
Nov 06Calculating The Intrinsic Value Of IRadimed Corporation (NASDAQ:IRMD)
Oct 13At US$41.26, Is It Time To Put IRadimed Corporation (NASDAQ:IRMD) On Your Watch List?
Feb 05Iradimed withdraws FDA filing for new infusion pump; prelim Q3 revenue rises 13% Y/Y
Oct 10IRadimed: Record Revenue Could Translate To Share Price Appreciation
Aug 23Here's Why We Think IRadimed (NASDAQ:IRMD) Is Well Worth Watching
Aug 17iRadimed Non-GAAP EPS of $0.26 beats by $0.02, revenue of $12.7M beats by $0.06M
Jul 29IRadimed: Reduce Equity Beta With Upside Capture
Jul 18IRadimed (NASDAQ:IRMD) Might Be Having Difficulty Using Its Capital Effectively
Jul 13At US$48.60, Is IRadimed Corporation (NASDAQ:IRMD) Worth Looking At Closely?
Feb 05Here's What's Concerning About IRadimed's (NASDAQ:IRMD) Returns On Capital
Jan 12Returns On Capital At IRadimed (NASDAQ:IRMD) Paint A Concerning Picture
Jul 13iRadimed EPS beats by $0.04, beats on revenue
Apr 30iRadimed EPS misses by $0.02, beats on revenue
Feb 04If You Had Bought IRadimed (NASDAQ:IRMD) Stock Five Years Ago, You Could Pocket A 70% Gain Today
Jan 31Financial Position Analysis
Short Term Liabilities: IRMD's short term assets ($76.0M) exceed its short term liabilities ($16.3M).
Long Term Liabilities: IRMD's short term assets ($76.0M) exceed its long term liabilities ($4.4M).
Debt to Equity History and Analysis
Debt Level: IRMD is debt free.
Reducing Debt: IRMD had no debt 5 years ago.
Debt Coverage: IRMD has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: IRMD has no debt, therefore coverage of interest payments is not a concern.